Gianenrico E. Senna

Verona, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 252 publications

Anaphylaxis: from reaction-centered medicine to patient-centered susceptibility.

Anaphylaxis: from reaction-centered medicine to patient-centered susceptibility.

Journal: Current opinion in allergy and clinical immunology
Published: August 28, 2026

Dual REmission in moderate-to-severe AsthMa and nasal polyps: a multicentric observational phase IV real-life study (DREAM-NP).

Dual REmission in moderate-to-severe AsthMa and nasal polyps: a multicentric observational phase IV real-life study (DREAM-NP).

Journal: Expert opinion on biological therapy
Published: July 24, 2026

Real-world effectiveness of tezepelumab on clinical remission and small airway dysfunction in severe asthma: a 52-week prospective study.

Real-world effectiveness of tezepelumab on clinical remission and small airway dysfunction in severe asthma: a 52-week prospective study.

Journal: Expert opinion on biological therapy
Published: May 27, 2026

A four-year journey towards clinical remission and background therapies optimization with benralizumab: A retrospective analysis.

A four-year journey towards clinical remission and background therapies optimization with benralizumab: A retrospective analysis.

Journal: The World Allergy Organization journal
Published: April 08, 2026

Allergen Immunotherapy and Possible Clinical Remission: Toward a Disease-Modifying Paradigm in Allergic Disorders.

Allergen Immunotherapy and Possible Clinical Remission: Toward a Disease-Modifying Paradigm in Allergic Disorders.

Journal: Biomedicines
Published: April 06, 2026

Step-DAWN: an Italian algorithm proposed for the management of inhaled corticosteroids in severe asthma.

Step-DAWN: an Italian algorithm proposed for the management of inhaled corticosteroids in severe asthma.

Journal: Respiratory medicine
Published: March 24, 2026

Upper and lower airways response to tezepelumab in asthma patients with / without comorbid nasal polyposis: a 6-months reallife perspective.

Upper and lower airways response to tezepelumab in asthma patients with / without comorbid nasal polyposis: a 6-months reallife perspective.

Journal: Rhinology
Published: January 12, 2026

Upper and lower airways response to tezepelumab in asthma patients with / without comorbid nasal polyposis: a 6-months reallife perspective.

Upper and lower airways response to tezepelumab in asthma patients with / without comorbid nasal polyposis: a 6-months reallife perspective.

Journal: Rhinology
Published: January 12, 2026

Trends of T2 and Non-T2 Cytokines During Mepolizumab Treatment in Different Asthma Patient Subgroups.

Trends of T2 and Non-T2 Cytokines During Mepolizumab Treatment in Different Asthma Patient Subgroups.

Journal: Biomedicines
Published: December 31, 2025

Anaphylaxis and Epinephrine Use in Pregnancy.

Anaphylaxis and Epinephrine Use in Pregnancy.

Journal: The journal of allergy and clinical immunology. In practice
Published: December 30, 2025

Clinical Remission in Chronic Rhinosinusitis With Nasal Polyps: a Delphi Consensus from the Rhinosinusitis Italian Network (RINET).

Clinical Remission in Chronic Rhinosinusitis With Nasal Polyps: a Delphi Consensus from the Rhinosinusitis Italian Network (RINET).

Journal: The journal of allergy and clinical immunology. In practice
Published: December 12, 2025

De-escalation of inhaled corticosteroids and other maintenance asthma therapies in dupilumab-treated patients with severe asthma: a real-world study.

De-escalation of inhaled corticosteroids and other maintenance asthma therapies in dupilumab-treated patients with severe asthma: a real-world study.

Journal: Respiratory medicine
Published: November 24, 2025
Showing 1-12 of 252

Last Updated: 09/26/2026